The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)
Open accessAbstract
Reactive oxygen species (ROS) have an established role in inflammation and host defense, as they kill intracellular bacteria and have been shown to activate the NLRP3 inflammasome. Here, we find that ROS generated by mitochondrial respiration are important for normal lipopolysaccharide (LPS)-driven production of several proinflammatory cytokines and for the enhanced responsiveness to LPS seen in cells from patients with tumor necrosis factor receptor-associated periodic syndrome (TRAPS), an autoinflammatory disorder caused by missense mutations in the type 1 TNF receptor (TNFR1). We find elevated baseline ROS in both mouse embryonic fibroblasts and human immune cells harboring TRAPS-associated TNFR1 mutations. A variety of antioxidants dampen LPS-induced MAPK phosphorylation and inflammatory cytokine production. However, gp91phox and p22phox reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits are dispensable for inflammatory cytokine production, indicating that NADPH oxidases are not the source of proinflammatory ROS. TNFR1 mutant cells exhibit altered mitochondrial function with enhanced oxidative capacity and mitochondrial ROS generation, and pharmacological blockade of mitochondrial ROS efficiently reduces inflammatory cytokine production after LPS stimulation in cells from TRAPS patients and healthy controls. These findings suggest that mitochondrial ROS may be a novel therapeutic target for TRAPS and other inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these mtROS also contribute to oxidative stress through the oxidation of surrounding biomolecules, eventually culminating in uncontrolled inflammation, production of neoantigens, DNA damage and DNA mutations60–63”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Not surprisingly, the NLRP3 inflammasome was, with exception for IL-1β, not involved in cytokine secretion as NLRP3-, Caspase-1- and Caspase 1l-deficient macrophages showed normal secretion of TNF and IL-6 (see Section 4.3).”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
Experimental — accuracy not yet measuredIn the citing paper
“TNFR1-deficient macrophages stimulated with LPS showed enhanced secretion of IL-6, TNF and IL-1β.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
In the citing paper
“MEF treated with LPS and MitoQ showed reduced levels of IL-6, which, unfortunately, is the only connection between mtROS and cytokine secretion investigated in this study.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
In the citing paper
“Moreover, macrophages lacking the p22phox subunit showed cytokine secretion similar to Nox2-deficient macrophages, nicely showing that Nox enzymes were dispensable for cytokine secretion after LPS stimulation.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydroperoxide metabolism in mammalian organs.
Chance, B., Sies, H., & Boveris, A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.527 · Cited by 5,827 · cited 2×
“These results identify mitochondria, which are a major source of physiological cellular ROS (Chance et al., 1979; Balaban et al., 2005), in the genesis of ROS that drive inflammation.”
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 2×
“Although it has recently been shown that mitochondrial damage and inhibition of mitophagy can activate the NLRP3 inflammasome and IL-1 cleavage in a ROS-dependent manner (Zhou et al., 2010b), our results suggest a more general role for mitochondrial ROS in the induction of inflammatory cytokines upstream of inflammas…”
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388 · cited 2×
“These results identify mitochondria, which are a major source of physiological cellular ROS (Chance et al., 1979; Balaban et al., 2005), in the genesis of ROS that drive inflammation.”
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 2×
“Mice with a null allele of the gene involved in X-linked CGD, gp91phox, which encodes the 91-kD subunit of the burst (Nathan, 2006).”
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · cited 6×
“ROS have been implicated in the activation of the NLRP3 inflammasome, which results in IL-1 processing and secretion through activation of caspase-1 (Cruz et al., 2007; Zhou et al., 2010a).”
InfluentialInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658 · cited 1×
“…oxygen species (ROS) have been implicated in inflammatory diseases including rheumatoid arthritis (Filippin et al., 2008), multiple sclerosis (Gilgun-Sherki et al., 2004), thyroiditis (Burek and Rose, 2008), and type 1 diabetes (Chen et al., 2008).”
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,655
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445 · cited 2×
“…implicated as the source of ROS in inflammasome activation, as antioxidants thought to block NOXs and knockdown of p22 phagocyte oxidase (phox), a common subunit of four NOXs, resulted in diminished NLRP3 activation upon stimulation (Cruz et al., 2007; Pétrilli et al., 2007; Dostert et al., 2008).”
Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., & Robinson, J. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210432200 · Cited by 1,433 · cited 2×
“Although rotenone has been shown to both increase and decrease mitochondrial ROS production in a variety of cell types (Li et al., 2003; Thompson et al., 2007),”
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173 · cited 1×
“Mitoquinone (MitoQ), a coenzyme Q10 analogue that acts as a ROS scavenger, contains a lipophilic triphenylphosphonium cation that causes the antioxidant to accumulate several hundredfold within mitochondria because of the high mitochondrial membrane potential (Murphy and Smith, 2007; Villalba et al., 2010).”
Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo
Meng, T.-C., Fukada, T., & Tonks, N. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00445-8 · Cited by 1,040 · cited 1×
“ROS can potentiate MAPK activation by inactivation of MAPK phosphatases through oxidation of their catalytic cysteine residues (Meng et al., 2002; Reth, 2002; Kamata et al., 2005).”
Cárdenas, C., Miller, R. A., Smith, I., Bui, T., Molgó, J., Müller, M., Vais, H., Cheung, K.-H., Yang, J., Parker, I., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.007 · Cited by 1,026 · cited 1×
“The endoplasmic reticulum, where mutant TNFR1 resides, can provide signals to activate mitochondrial respiration, including a calcium signal transduced by mitochondrial InsP3 receptors (Cárdenas et al., 2010).”
TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages
Martinon, F., Chen, X., Lee, A.-H., & Glimcher, L. H. (2010) · Nature Immunology · doi:10.1038/ni.1857 · Cited by 996
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930 · cited 1×
“However, DPI was later shown to be less potent as an inhibitor of mitochondrial oxidative phosphorylation than NOX enzymes (Hancock and Jones, 1987) and nitric oxide synthases (Stuehr et al., 1991).”
Self-citationPollock, J. D., Williams, D. A., Gifford, M. A. C., Li, L. L., Du, X., Fisherman, J., Orkin, S. H., Doerschuk, C. M., & Dinauer, M. C. (1995) · Nature Genetics · doi:10.1038/ng0295-202 · Cited by 921 · cited 3×
“523 have increased neutrophil infiltration in a sterile peritonitis model (Pollock et al., 1995).”
InfluentialRegulation of superoxide dismutase genes: Implications in disease
Miao, L., & St. Clair, D. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.018 · Cited by 912
Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L. M., Persechini, P. M., & Ojcius, D. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608083200 · Cited by 786 · cited 2×
“…implicated as the source of ROS in inflammasome activation, as antioxidants thought to block NOXs and knockdown of p22 phagocyte oxidase (phox), a common subunit of four NOXs, resulted in diminished NLRP3 activation upon stimulation (Cruz et al., 2007; Pétrilli et al., 2007; Dostert et al., 2008).”
BackgroundHydrogen peroxide as second messenger in lymphocyte activation
Reth, M. (2002) · Nature Immunology · doi:10.1038/ni1202-1129 · Cited by 779 · cited 1×
“ROS can potentiate MAPK activation by inactivation of MAPK phosphatases through oxidation of their catalytic cysteine residues (Meng et al., 2002; Reth, 2002; Kamata et al., 2005).”
Offen, D., Gilgun-Sherki, Y., & Melamed, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0348-9 · Cited by 638 · cited 1×
“…or IL-1 receptor antagonist, are specifically associated with IL-1 overproduction or excessive IL-1 signaling, and IL-1 blockade in these fever syndromes results in normalization of inflammatory parameters and robust clinical responses (Hoffman et al., 2004; Goldbach-Mansky et al., 2006).”
Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G., & Fiers, W. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05978.x · Cited by 577 · cited 2×
“…concept, Rho zero L929 cells that lack mitochondrial DNA and an intact mitochondrial respiratory chain have decreased production of IL-6 in response to TNF, although these results must be interpreted with caution given the dramatic metabolic changes in these cells (Schulze-Osthoff et al., 1993).”
Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 569 · cited 1×
“This suggests that the efficacy of the antioxidants correlates with dependency on MAPKs, as induction of IL-6, TNF, CXCL8/IL-8, and IL-10 are dependent on MAPKs (Scherle et al., 1998; Chi et al., 2006).”
BackgroundHoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L., Anderson, J. P., Wanderer, A. A., & Firestein, G. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17401-1 · Cited by 552 · cited 2×
“In fact, DPI was first identified as an inhibitor of mitochondria (Holland and Sherratt, 1972), as it blocks the flavin components of the electron transport chain.”
Shiloh, M. U., MacMicking, J. D., Nicholson, S., Brause, J. E., Potter, S., Marino, M., Fang, F., Dinauer, M., & Nathan, C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80004-7 · Cited by 508 · cited 1×
“NADPH oxidase (NOX)– derived ROS are critical in host defense, as patients with chronic granulomatous disease (CGD) or mice engineered to lack components of the NOXs have increased susceptibility to infection (Morgenstern et al., 1997; Shiloh et al., 1999).”
Takada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S., & Aggarwal, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212389200 · Cited by 495 · cited 1×
“…implicated in the activation of signaling pathways such as mitogen-activated protein kinases (MAPK), NF-B, and guanylate cyclase (Schmidt, 1992; Takada et al., 2003; Kamata et al., 2005), and have been shown to modulate B cell receptor signaling (Capasso et al., 2010), mast cell activation…”
Li, Y., & Trush, M. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9729 · Cited by 478 · cited 1×
“DPI has been shown to block mitochondrial ROS, which are produced as a consequence of electron leak during the electron transport chain (Li and Trush, 1998); it inhibits flavin adenine dinucleotide (FAD), which is present in both complex I (NADH-quinone oxidoreductase) and complex II (succinyl dehydrogenase).”
Stuehr, D. J., Fasehun, O. A., Kwon, N. S., Gross, S. S., Gonzalez, J. A., Levi, R., & Nathan, C. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.1.1703974 · Cited by 464
Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling
Nathan, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18174 · Cited by 456
HULL, K. M., DREWE, E., AKSENTIJEVICH, I., SINGH, H. K., WONG, K., MCDERMOTT, E. M., DEAN, J., POWELL, R. J., & KASTNER, D. L. (2002) · Medicine · doi:10.1097/00005792-200209000-00002 · Cited by 455 · cited 1×
“…provide an alternate source of ROS that allows normal or enhanced inflammatory responses in the setting of NOX deficiency (van de Loo et al., 2003; Hultqvist et al., 2004; George-Chandy et al., 2008; Meissner et al., 2010; van de Veerdonk et al., 2010) and may explain the associated inflammatory…”
Self-citationMorgenstern, D. E., Gifford, M. A. C., Li, L. L., Doerschuk, C. M., & Dinauer, M. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.207 · Cited by 370 · cited 1×
“NADPH oxidase (NOX)– derived ROS are critical in host defense, as patients with chronic granulomatous disease (CGD) or mice engineered to lack components of the NOXs have increased susceptibility to infection (Morgenstern et al., 1997; Shiloh et al., 1999).”
Hultqvist, M., Olofsson, P., Holmberg, J., Bäckström, B. T., Tordsson, J., & Holmdahl, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403831101 · Cited by 346 · cited 4×
“ROS can potentiate MAPK activation by inactivation of MAPK phosphatases through oxidation of their catalytic cysteine residues (Meng et al., 2002; Reth, 2002; Kamata et al., 2005).”
InfluentialRedox signalling and the inflammatory response in rheumatoid arthritis
Filippin, L. I., Vercelino, R., Marroni, N. P., & Xavier, R. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03634.x · Cited by 326 · cited 1×
“…of ROS that allows normal or enhanced inflammatory responses in the setting of NOX deficiency (van de Loo et al., 2003; Hultqvist et al., 2004; George-Chandy et al., 2008; Meissner et al., 2010; van de Veerdonk et al., 2010) and may explain the associated inflammatory symptoms seen in CGD…”
Infevers: An evolving mutation database for auto-inflammatory syndromes
Touitou, I., Lesage, S., McDermott, M., Cuisset, L., Hoffman, H., Dode, C., Shoham, N., Aganna, E., Hugot, J.-P., Wise, C., et al. (2004) · Human Mutation · doi:10.1002/humu.20080 · Cited by 322 · cited 1×
“TRAPS is caused by mutations in the extracellular domain of the gene encoding TNF receptor 1 (TNFR1, TNFRSF1A, CD120a, and p55TNFR), and >50 individual mutations have been identified to date (Touitou et al., 2004).”
Ero1 and redox homeostasis in the endoplasmic reticulum
Sevier, C. S., & Kaiser, C. A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.12.011 · Cited by 305 · cited 1×
“ROS have many sources, including peroxisomes, ubiquinone, cytosolic enzymes including cyclooxygenase, uncoupled nitric oxide synthases, and ERO1 in the endoplasmic reticulum (Landmesser et al., 2003; Sevier and Kaiser, 2008).”
Meissner, F., Seger, R. A., Moshous, D., Fischer, A., Reichenbach, J., & Zychlinsky, A. (2010) · Blood · doi:10.1182/blood-2010-01-264218 · Cited by 269 · cited 2×
“…or enhanced inflammatory responses in the setting of NOX deficiency (van de Loo et al., 2003; Hultqvist et al., 2004; George-Chandy et al., 2008; Meissner et al., 2010; van de Veerdonk et al., 2010) and may explain the associated inflammatory symptoms seen in CGD patients alongside their…”
Scherle, P. A., Jones, E. A., Favata, M. F., Daulerio, A. J., Covington, M. B., Nurnberg, S. A., Magolda, R. L., & Trzaskos, J. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5681 · Cited by 256 · cited 4×
“IFN- and CCL5/RANTES production in response to LPS was unaffected by the addition of MitoQ, suggesting that the efficacy of MitoQ is through its action on MAPKs and To more directly measure mitochondrial ROS production in cells harboring TNFR1 mutations, we used MitoSOX Red.”
Influentialvan de Veerdonk, F. L., Smeekens, S. P., Joosten, L. A. B., Kullberg, B. J., Dinarello, C. A., van der Meer, J. W. M., & Netea, M. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914795107 · Cited by 248 · cited 5×
“…in the setting of NOX deficiency (van de Loo et al., 2003; Hultqvist et al., 2004; George-Chandy et al., 2008; Meissner et al., 2010; van de Veerdonk et al., 2010) and may explain the associated inflammatory symptoms seen in CGD patients alongside their immunodeficiency (Rosenzweig, 2008).”
InfluentialLobito, A. A., Kimberley, F. C., Muppidi, J. R., Komarow, H., Jackson, A. J., Hull, K. M., Kastner, D. L., Screaton, G. R., & Siegel, R. M. (2006) · Blood · doi:10.1182/blood-2005-11-006783 · Cited by 229 · cited 1×
“Although rotenone has been shown to both increase and decrease mitochondrial ROS production in a variety of cell types (Li et al., 2003; Thompson et al., 2007), (A) The effect of antioxidants on oxygen consumption rate was measured in WT MEFs with a Seahorse Bioscience XF Analyzer.”
MethodSelf-citationCapasso, M., Bhamrah, M. K., Henley, T., Boyd, R. S., Langlais, C., Cain, K., Dinsdale, D., Pulford, K., Khan, M., Musset, B., et al. (2010) · Nature Immunology · doi:10.1038/ni.1843 · Cited by 223 · cited 2×
“, 2005), and have been shown to modulate B cell receptor signaling (Capasso et al., 2010), mast cell activation (Tagen et al.”
Riboflavin kinase couples TNF receptor 1 to NADPH oxidase
Yazdanpanah, B., Wiegmann, K., Tchikov, V., Krut, O., Pongratz, C., Schramm, M., Kleinridders, A., Wunderlich, T., Kashkar, H., Utermöhlen, O., et al. (2009) · Nature · doi:10.1038/nature08206 · Cited by 216 · cited 1×
“Mutant TNFR1 may increase activation of riboflavin kinase, which can associate with TNFR1 (Yazdanpanah et al., 2009), leading to enhanced charging of FAD-dependent enzymes in the mitochondria.”
The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages
Hancock, J. T., & Jones, O. T. (1987) · Biochemical Journal · doi:10.1042/bj2420103 · Cited by 209 · cited 1×
“…or IL-1 receptor antagonist, are specifically associated with IL-1 overproduction or excessive IL-1 signaling, and IL-1 blockade in these fever syndromes results in normalization of inflammatory parameters and robust clinical responses (Hoffman et al., 2004; Goldbach-Mansky et al., 2006).”
BackgroundSimon, A., Park, H., Maddipati, R., Lobito, A. A., Bulua, A. C., Jackson, A. J., Chae, J. J., Ettinger, R., de Koning, H. D., Cruz, A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914118107 · Cited by 196 · cited 17×
“Although NAC has been shown to inhibit the activation of both NF-B and IRF3, we have not seen increased activation of NF-B or IRF3, or increased production of the IRF3dependent cytokine CCL5/RANTES in TRAPS (Simon et al., 2010).”
InfluentialSelf-citationNO•, CO and •OH Endogenous soluble guanylyl cyclase‐activating factors
Schmidt, H. H. H. W. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80910-9 · Cited by 185
Sellak, H., Franzini, E., Hakim, J., & Pasquier, C. (1994) · Blood · doi:10.1182/blood.v83.9.2669.2669 · Cited by 172
Ravet, N., Rouaghe, S., Dodé, C., Bienvenu, J., Stirnemann, J., Lévy, P., Delpech, M., & Grateau, G. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048611 · Cited by 172 · cited 2×
“inflammatory symptoms and rare development of amyloidosis (Ravet et al., 2006).”
Autoimmune thyroiditis and ROS
Burek, C. L., & Rose, N. R. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.006 · Cited by 159 · cited 1×
“, 2004), thyroiditis (Burek and Rose, 2008), and type 1 diabetes (Chen et al.”
Tassi, S., Carta, S., Delfino, L., Caorsi, R., Martini, A., Gattorno, M., & Rubartelli, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000779107 · Cited by 153 · cited 2×
“Recent work has demonstrated elevated baseline levels of ROS in the autoinflammatory cryopyrin-associated periodic syndromes (CAPS; Tassi et al., 2010).”
Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations
Villalba, J. M., Parrado‐Fernández, C., González, M. S., & Alcain, F. J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003727495 · Cited by 139 · cited 2×
“…(MitoQ), a coenzyme Q10 analogue that acts as a ROS scavenger, contains a lipophilic triphenylphosphonium cation that causes the antioxidant to accumulate several hundredfold within mitochondria because of the high mitochondrial membrane potential (Murphy and Smith, 2007; Villalba et al., 2010).”
Inflammatory Manifestations in Chronic Granulomatous Disease (CGD)
Rosenzweig, S. D. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9160-5 · Cited by 137 · cited 2×
“, 2010) and may explain the associated inflammatory symptoms seen in CGD patients alongside their immunodeficiency (Rosenzweig, 2008).”
Production of reactive oxygen species in mitochondria of HeLa cells under oxidative stress
Chernyak, B. V., Izyumov, D. S., Lyamzaev, K. G., Pashkovskaya, A. A., Pletjushkina, O. Y., Antonenko, Y. N., Sakharov, D. V., WIRTZ, K. W. A., & Skulachev, V. P. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.02.019 · Cited by 128
Bylund, J., MacDonald, K. L., Brown, K. L., Mydel, P. M., Collins, L. V., Hancock, R. E. W., & Speert, D. P. (2007) · European Journal of Immunology · doi:10.1002/eji.200636651 · Cited by 118 · cited 2×
“Despite this immunodeficiency, macrophages from gp91phox-null mice, as well as CGD patients, produce increased inflammatory cytokines in response to sterile innate stimuli such as LPS (Bylund et al., 2007) and”
Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice
Nakano, Y., Longo-Guess, C. M., Bergstrom, D. E., Nauseef, W. M., Jones, S. M., & Bánfi, B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33835 · Cited by 112 · cited 2×
“To determine whether a NOX family member besides NOX2 may be responsible for ROS generation and the subsequent inflammatory sequelae in the CGD model and in TRAPS, we studied NMF333 mice, which harbor a naturally occurring mutation in the p22phox subunit common to NOX1, 2, 3, and 4 (Nakano et al., 2008).”
Pani, G., Koch, O. R., & Galeotti, T. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.011 · Cited by 97 · cited 2×
“The increased MnSOD expression we find in TNFR1 mutant cells is an indicator of chronic oxidative stress (Miao and St Clair, 2009; Pani et al., 2009) that may feed back and cause even more dysregulated inflammation.”
Todd, I., Radford, P. M., Draper‐Morgan, K., McIntosh, R. S., Bainbridge, S., Dickinson, P., Jamhawi, L., Sansaridis, M., Huggins, M. L., Tighe, P. J., et al. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01942.x · Cited by 96 · cited 1×
“TNFR1 molecules harboring TRAPS-associated mutations fail to interact with WT TNFR1 receptors or TNF and traffic abnormally in the cell, with retention and accumulation in the endoplasmic reticulum (Todd et al., 2004; Lobito et al., 2006; Simon et al., 2010).”
van de Loo, F. A. J., Bennink, M. B., Arntz, O. J., Smeets, R. L., Lubberts, E., Joosten, L. A. B., van Lent, P. L. E. M., Roo, C. J. J. C., Cuzzocrea, S., Segal, B. H., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63509-2 · Cited by 96 · cited 1×
“…Mitochondrial ROS may provide an alternate source of ROS that allows normal or enhanced inflammatory responses in the setting of NOX deficiency (van de Loo et al., 2003; Hultqvist et al., 2004; George-Chandy et al., 2008; Meissner et al., 2010; van de Veerdonk et al., 2010) and may explain the…”
BackgroundYang, Q., Kim, Y., Lin, Y., Lewis, J., Neckers, L., & Liu, Z. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400687 · Cited by 90 · cited 1×
“In addition, TNFR1 has been shown to sense ER stress and mediate ER stress–induced JNK activation (Yang et al., 2006).”
Hereditary auto-inflammatory disorders and biologics
Church, L. D., Churchman, S. M., Hawkins, P. N., & McDermott, M. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0015-6 · Cited by 76 · cited 2×
“…implicated as the source of ROS in inflammasome activation, as antioxidants thought to block NOXs and knockdown of p22 phagocyte oxidase (phox), a common subunit of four NOXs, resulted in diminished NLRP3 activation upon stimulation (Cruz et al., 2007; Pétrilli et al., 2007; Dostert et al., 2008).”
Th17 development and autoimmune arthritis in the absence of reactive oxygen species
George‐Chandy, A., Nordström, I., Nygren, E., Jonsson, I., Postigo, J., Collins, L. V., & Eriksson, K. (2008) · European Journal of Immunology · doi:10.1002/eji.200737348 · Cited by 68 · cited 1×
“…of ROS that allows normal or enhanced inflammatory responses in the setting of NOX deficiency (van de Loo et al., 2003; Hultqvist et al., 2004; George-Chandy et al., 2008; Meissner et al., 2010; van de Veerdonk et al., 2010) and may explain the associated inflammatory symptoms seen in CGD…”
Mitochondrial Uncoupling Protein 2 Inhibits Mast Cell Activation and Reduces Histamine Content
Tagen, M., Elorza, Á. A., Kempuraj, D., Boucher, W. S., Kepley, C. L., Shirihai, O. S., & Theoharides, T. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803422 · Cited by 62
Thompson, R. J., Buttigieg, J. A., Zhang, M., & Nurse, C. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.040 · Cited by 58 · cited 2×
“Although rotenone has been shown to both increase and decrease mitochondrial ROS production in a variety of cell types (Li et al., 2003; Thompson et al., 2007),”
Kanayama, A., & Miyamoto, Y. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407259 · Cited by 46 · cited 1×
“…roles in immune responses to pathogens, including bacterial killing through the production of superoxide by reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidases during the respiratory burst in activated macrophages and neutrophils (Lambeth, 2004; Kanayama and Miyamoto, 2007).”
BackgroundHolland, P. C., & Sherratt, H. S. A. (1972) · Biochemical Journal · doi:10.1042/bj1290039 · Cited by 42 · cited 2×
“In fact, DPI was first identified as an inhibitor of mitochondria (Holland and Sherratt, 1972), as it blocks the flavin components of the electron transport chain.”
BackgroundMethodRole of Increased ROS Dissipation in Prevention of T1D
Chen, J., Gusdon, A. M., Thayer, T. C., & Mathews, C. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.045 · Cited by 40 · cited 2×
“…oxygen species (ROS) have been implicated in inflammatory diseases including rheumatoid arthritis (Filippin et al., 2008), multiple sclerosis (Gilgun-Sherki et al., 2004), thyroiditis (Burek and Rose, 2008), and type 1 diabetes (Chen et al., 2008).”
Cited by
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
“Interestingly, patients with tumor necrosis factor receptor-associated periodic syndrome (TRAPS) have heightened responsiveness to LPS, due to increased mitochondrial ROS production, which promotes inflammation, again suggesting that redox biology, and not oxidative stress, is regulating inflammatory diseases [90].”
BackgroundReactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897
“Monocytes and neutrophils isolated from TRAPS patients showed elevated baseline levels of mitochondrial ROS compared with healthy donors and also had constitutive and prolonged activation of JNK and p38 MAPK on LPS challenge (48).”
InfluentialPhysiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Signal transduction by reactive oxygen species
Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322
Metadata
- Authors
- Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.-Y., Sack, M. N., Kastner, D. L., & Siegel, R. M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Siegel, Richard M.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-01-31
- Volume
- 208
- Issue
- 3
- Pages
- 519-533
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3058571
- OpenAlex
- W2119828139
- Cited by
- 860
- References
- 65
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 41 · 2023: 58 · 2022: 55 · 2021: 64 · 2020: 58 · 2019: 59 · 2018: 56 · 2017: 65 · 2016: 52 · 2015: 62 · 2014: 65 · 2013: 71 · 2012: 62
- FWCI
- 30.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mitochondrial reactive oxygen species, tumor necrosis factor receptor-associated periodic syndrome, inflammatory cytokines, lipopolysaccharide response, autoinflammatory disease, NADPH oxidase, gp91phox, p22phox, mitochondrial respiration, MAPK signaling, antioxidants, therapeutic target
- MeSH terms
- Animals, Humans, Inflammation, Mice, Mutant Strains, Mitochondria, Mutation, Nitric Oxide, Signal Transduction, Interleukin-6, Cytokines, Reactive Oxygen Species, Mitogen-Activated Protein Kinase Kinases, Receptors, Tumor Necrosis Factor, Type I, Mice, Cryopyrin-Associated Periodic Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.